REFERENCES
- Ambar I, Sokolovsky M. Endothelin receptors stimulate both phospholipase C and phospholipase D activities in different cell lines. Eur J Pharmacol 1993; 245: 31–41, [PUBMED], [INFOTRIEVE], [CSA]
- Bohm F, Beltran E, Pernow J. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition. J Intern Med 2005; 257: 263–271, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bruno C M, Meli S, Marcinno M, Ierna D, Sciacca C, Neri S. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents 2002; 16: 114–117, [PUBMED], [INFOTRIEVE], [CSA]
- Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Piperi C, Papamichael C, Aessopos A, Lekakis J, Mavrikakis M. Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol 2005; 152: 749–756, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 2001; 86: 4666–4673, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dincer U D, Araiza A G, Knudson J D, Varela J, Williams K C, Molina P E, Tune J D. Alpha-1-adrenoceptor-mediated coronary vasoconstriction is enhanced in the prediabetic metabolic syndrome. Cir 2005; 112(II)66–67, [CSA]
- Ergul A, Johansen J S, Stromhaug C, Harris A K, Hutchinson J, Tawfik A, Rahimi A, Rhim E, Wells B, Caldwell R W, Anstadt M P. Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1. J Pharmacol Exp Ther 2005; 313: 70–77, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Feigl E O, Neat G W, Huang A H. Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. J Mol Cell Cardiol 1990; 22: 375–390, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fernandez N, Martinez M A, Garcia-Villalon A L, Monge L, Dieguez G. Coronary action of endothelin-1 and vasopressin during acute hypertension in anesthetized goats: role of nitric oxide and prostanoids. Vascul Pharmacol 2004; 41: 131–138, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A, De Mattia G. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997; 105(Suppl 2)38–40, [PUBMED], [INFOTRIEVE], [CSA]
- Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gorman M W, Farias M, III, Richmond K N, Tune J D, Feigl E O. Role of endothelin in alpha-adrenoceptor coronary vasoconstriction. Am J Physiol Heart Circ Physiol 2005; 288: H1937–H1942, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grundy S M, Benjamin I J, Burke G L, Chait A, Eckel R H, Howard B V, Mitch W, Smith S C, Jr, Sowers J R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134–1146, [PUBMED], [INFOTRIEVE], [CSA]
- Guner S, Arioglu E, Tay A, Tasdelen A, Aslamaci S, Bidasee K R, Dincer U D. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem 2004; 263: 143–150, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Henry P, Thomas F, Benetos A, Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 2002; 40: 458–463, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hopfner R L, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia 1999; 42: 1383–1394, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hopfner R L, Hasnadka R V, Wilson T W, McNeill J R, Gopalakrishnan V. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes 1998; 47: 937–944, [PUBMED], [INFOTRIEVE], [CSA]
- Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M R, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689, [PUBMED], [INFOTRIEVE], [CSA]
- Jones C J, Kuo L, Davis M J, De Fily D V, Chilian W M. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995; 91: 1807–1813, [PUBMED], [INFOTRIEVE], [CSA]
- Kaiyala K J, Prigeon R L, Kahn S E, Woods S C, Porte D, Jr, Schwartz M W. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol 1999; 277: E659–E667, [PUBMED], [INFOTRIEVE], [CSA]
- Knudson J D, Dincer U D, Dick G M, Shibata H, Akahane R, Saito M, Tune J D. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1038–H1046, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knudson J D, Dincer U D, Zhang C, Swafford A N, Jr, Koshida R, Picchi A, Focardi M, Dick G M, Tune J D. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H48–H56, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kuo L, Chilian W M, Davis M J. Interaction of pressure-and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 1991; 261: H1706–H1715, [PUBMED], [INFOTRIEVE], [CSA]
- Lakka H M, Laaksonen D E, Lakka T A, Niskanen L K, Kumpusalo E, Tuomilehto J, Salonen J T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luscher T F, Yang Z, Kiowski W, Linder L, Dohi Y, Diederich D. Endothelin-induced vasoconstriction and calcium antagonists. J Hum Hypertens 1992; 6(Suppl 2)S3–S8, [PUBMED], [INFOTRIEVE], [CSA]
- McNair L L, Salamanca D A, Khalil R A. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. Hypertension 2004; 43: 897–904, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Merkus D, Houweling B, van den Meiracker A H, Boomsma F, Duncker D J. Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol 2005; 288: H871–H880, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Muller-Wieland D, Kotzka J, Knebel B, Krone W. Metabolic syndrome and hypertension: pathophysiology and molecular basis of insulin resistance. Basic Res Cardiol 1998; 93(Suppl 2)131–134, [PUBMED], [INFOTRIEVE], [CSA]
- Piatti P M, Monti L D, Galli L, Fragasso G, Valsecchi G, Conti M, Gernone F, Pontiroli A E. Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism 2000; 49: 748–752, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Saltevo J, Puolakka J, Ylikorkala O. Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. Diabetes Obes Metab 2000; 2: 293–298, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Setty S, Sun W, Tune J D. Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 2003; 98: 416–423, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tenenbaum A, Motro M, Fisman E Z, Tanne D, Boyko V, Behar S. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med 2005; 165: 1154–1160, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trevisan M, Liu J, Bahsas F B, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998; 148: 958–966, [PUBMED], [INFOTRIEVE], [CSA]
- Tu J, Shan Q, Jin H, Bourreau J P, Xia Q. Endothelin-1-mediated coronary vasoconstriction deteriorates myocardial depression in hearts isolated from lipopolysaccharide-treated rats: interaction with nitric oxide. Clin Exp Pharmacol Physiol 2004; 31: 571–574, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu S Q, Hopfner R L, McNeill J R, Wilson T W, Gopalakrishnan V. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res 2000; 45: 994–1000, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yoshida M, Suzuki A, Itoh T. Mechanisms of vasoconstriction induced by endothelin-1 in smooth muscle of rabbit mesenteric artery. J Physiol 1994; 477(Pt 2)253–265, [PUBMED], [INFOTRIEVE], [CSA]
- Zeller M, Steg P G, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, Beer J C, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Verges B, Cottin Y. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192–1198, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang C, Knudson J D, Setty S, Araiza A, Dincer U D, Kuo L, Tune J D. Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol 2005; 288: H2154–H2162, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]